Em recrutamento
FASE
Número Europeu 2021-004450-36
MK-2140-006
A Multicenter, Open-label, Phase 2 Basket Study to Evaluate the Safety and Efficacy of MK-2140 as a Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies
Detalhes
Destaques